183 related articles for article (PubMed ID: 1452333)
21. Mutations affecting MHC class II binding of the superantigen streptococcal erythrogenic toxin A.
Hartwig UF; Fleischer B
Int Immunol; 1993 Aug; 5(8):869-75. PubMed ID: 8398982
[TBL] [Abstract][Full Text] [Related]
22. T-cell receptor Vβ8 for detection of biologically active streptococcal pyrogenic exotoxin type C.
Rasooly R; Do P; Hernlem B
J Dairy Sci; 2023 Oct; 106(10):6723-6730. PubMed ID: 37210361
[TBL] [Abstract][Full Text] [Related]
23. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.
Nemoto E; Rikiishi H; Sugawara S; Okamoto S; Tamura K; Maruyama Y; Kumagai K
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):81-91. PubMed ID: 8880132
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR
EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045
[TBL] [Abstract][Full Text] [Related]
25. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.
Mollick JA; Cook RG; Rich RR
Science; 1989 May; 244(4906):817-20. PubMed ID: 2658055
[TBL] [Abstract][Full Text] [Related]
26. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.
Braunstein NS; Weber DA; Wang XC; Long EO; Karp D
J Exp Med; 1992 May; 175(5):1301-5. PubMed ID: 1569399
[TBL] [Abstract][Full Text] [Related]
27. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity.
Leonard BA; Lee PK; Jenkins MK; Schlievert PM
Infect Immun; 1991 Mar; 59(3):1210-4. PubMed ID: 1997426
[TBL] [Abstract][Full Text] [Related]
28. Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.
Leonard BA; Schlievert PM
Infect Immun; 1992 Sep; 60(9):3747-55. PubMed ID: 1500185
[TBL] [Abstract][Full Text] [Related]
29. The superantigenic activity of streptococcal pyrogenic exotoxin B is independent of the protease activity.
Eriksson A; Norgren M
FEMS Immunol Med Microbiol; 1999 Sep; 25(4):355-63. PubMed ID: 10497866
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma-stimulated human vascular endothelial cells function as accessory cells for superantigen-induced TNF production in human T cells.
Imanishi K; Akatsuka H; Inada K; Uchiyama T
Int Arch Allergy Immunol; 1995 Feb; 106(2):163-5. PubMed ID: 7819745
[TBL] [Abstract][Full Text] [Related]
31. [Stimulation of the immune system by microbial "superantigens"].
Fleischer B
Immun Infekt; 1991 Feb; 19(1):8-11. PubMed ID: 2060968
[TBL] [Abstract][Full Text] [Related]
32. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
33. HLA class II polymorphisms determine responses to bacterial superantigens.
Llewelyn M; Sriskandan S; Peakman M; Ambrozak DR; Douek DC; Kwok WW; Cohen J; Altmann DM
J Immunol; 2004 Feb; 172(3):1719-26. PubMed ID: 14734754
[TBL] [Abstract][Full Text] [Related]
34. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.
Roggiani M; Stoehr JA; Leonard BA; Schlievert PM
Infect Immun; 1997 Jul; 65(7):2868-75. PubMed ID: 9199461
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen.
Sato H; Itoh T; Rikiishi H; Kumagai K
Microbiol Immunol; 1994; 38(2):139-47. PubMed ID: 8041301
[TBL] [Abstract][Full Text] [Related]
37. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
39. Antigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrier.
Radcliff FJ; Loh JM; Ha B; Schuhbauer D; McCluskey J; Fraser JD
Clin Vaccine Immunol; 2012 Apr; 19(4):574-86. PubMed ID: 22301693
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
